CN1053667C - 抑制3-取代的-2-羟吲哚的光分解 - Google Patents

抑制3-取代的-2-羟吲哚的光分解 Download PDF

Info

Publication number
CN1053667C
CN1053667C CN96105084A CN96105084A CN1053667C CN 1053667 C CN1053667 C CN 1053667C CN 96105084 A CN96105084 A CN 96105084A CN 96105084 A CN96105084 A CN 96105084A CN 1053667 C CN1053667 C CN 1053667C
Authority
CN
China
Prior art keywords
red
thienyl
dye
compound
lake
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN96105084A
Other languages
English (en)
Chinese (zh)
Other versions
CN1139110A (zh
Inventor
W·C·纽林
S·M·劳克林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN1139110A publication Critical patent/CN1139110A/zh
Application granted granted Critical
Publication of CN1053667C publication Critical patent/CN1053667C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
CN96105084A 1995-04-24 1996-04-22 抑制3-取代的-2-羟吲哚的光分解 Expired - Fee Related CN1053667C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
WOPCT/TB95/00287 1995-04-24
PCT/IB1995/000287 WO1996033701A1 (fr) 1995-04-24 1995-04-24 Inhibition de la photodecomposition des 2-oxindoles-3-substitues

Publications (2)

Publication Number Publication Date
CN1139110A CN1139110A (zh) 1997-01-01
CN1053667C true CN1053667C (zh) 2000-06-21

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96105084A Expired - Fee Related CN1053667C (zh) 1995-04-24 1996-04-22 抑制3-取代的-2-羟吲哚的光分解

Country Status (30)

Country Link
EP (1) EP0827399A1 (fr)
JP (1) JPH10506635A (fr)
KR (1) KR100189585B1 (fr)
CN (1) CN1053667C (fr)
AP (1) AP607A (fr)
AR (1) AR002728A1 (fr)
AU (1) AU692378B2 (fr)
BG (1) BG100531A (fr)
BR (1) BR9602024A (fr)
CO (1) CO4700418A1 (fr)
FI (1) FI973988A0 (fr)
HR (1) HRP960194A2 (fr)
HU (1) HU216544B (fr)
IL (1) IL117969A0 (fr)
IS (1) IS4339A (fr)
MA (1) MA23848A1 (fr)
NO (1) NO961622L (fr)
NZ (1) NZ286432A (fr)
OA (1) OA10286A (fr)
PE (1) PE34397A1 (fr)
RO (1) RO113305B1 (fr)
RU (1) RU2109510C1 (fr)
SG (1) SG64924A1 (fr)
SI (1) SI9600133A (fr)
SK (1) SK51296A3 (fr)
TR (1) TR199600300A2 (fr)
UA (1) UA42739C2 (fr)
WO (1) WO1996033701A1 (fr)
YU (1) YU25096A (fr)
ZA (1) ZA963210B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3085172A1 (fr) 2017-12-29 2019-07-04 Kraft Foods Group Brands Llc Stabilite oxydative amelioree d'emulsions huile dans eau a l'aide de stabilisants naturels

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2246072A (en) * 1990-07-20 1992-01-22 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical compositions stabilised against light
WO1994007488A1 (fr) * 1992-10-07 1994-04-14 Pfizer Inc. Compositions pharmaceutiques de 2-oxindole-1-carboxamide a substitution en position 3

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2246072A (en) * 1990-07-20 1992-01-22 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical compositions stabilised against light
WO1994007488A1 (fr) * 1992-10-07 1994-04-14 Pfizer Inc. Compositions pharmaceutiques de 2-oxindole-1-carboxamide a substitution en position 3

Also Published As

Publication number Publication date
MA23848A1 (fr) 1996-12-31
AP607A (en) 1997-08-27
SG64924A1 (en) 1999-05-25
AP9600787A0 (en) 1996-04-30
HUP9601057A2 (en) 1997-04-28
TR199600300A2 (tr) 1996-11-21
IL117969A0 (en) 1996-08-04
AU692378B2 (en) 1998-06-04
BR9602024A (pt) 1998-10-06
AR002728A1 (es) 1998-04-29
OA10286A (en) 1997-09-19
HU9601057D0 (en) 1996-06-28
IS4339A (is) 1996-10-25
CO4700418A1 (es) 1998-12-29
NO961622D0 (no) 1996-04-23
BG100531A (bg) 1997-06-30
AU5085196A (en) 1996-11-07
YU25096A (sh) 1998-08-14
WO1996033701A1 (fr) 1996-10-31
ZA963210B (en) 1997-10-23
RU2109510C1 (ru) 1998-04-27
CN1139110A (zh) 1997-01-01
HUP9601057A3 (en) 1997-05-28
SI9600133A (en) 1996-10-31
PE34397A1 (es) 1997-09-29
NO961622L (no) 1996-10-25
JPH10506635A (ja) 1998-06-30
FI973988A7 (fi) 1997-10-17
FI973988L (fi) 1997-10-17
SK51296A3 (en) 1997-04-09
KR960037656A (ko) 1996-11-19
UA42739C2 (uk) 2001-11-15
RO113305B1 (ro) 1998-06-30
NZ286432A (en) 1998-05-27
EP0827399A1 (fr) 1998-03-11
HU216544B (hu) 1999-07-28
FI973988A0 (fi) 1997-10-17
KR100189585B1 (ko) 1999-06-01
HRP960194A2 (en) 1998-02-28

Similar Documents

Publication Publication Date Title
CA2025668C (fr) Utilisation de l'omeprazole comme agent antimicrobien
JP6084161B2 (ja) ７−［４−（４−ベンゾ［ｂ］チオフェン−４−イル−ピペラジン−１−イル）ブトキシ］−１Ｈ−キノリン−２−オン又はその塩を含む錠剤
CN103705486A (zh) 胶囊制剂
US20110020408A1 (en) multilayered modified release formulation comprising amoxicillin and clavulanate
EP1663193A1 (fr) Derives de sulfonamide pour le traitement du diabete
JP2007308713A (ja) カプセル用のポリマーフィルム組成物
BRPI0510419B1 (pt) Comprimido revestido e método para preparar um comprimido revestido.
KR870009718A (ko) 경구용 산에 불안정한물질의 약제
JPH064531B2 (ja) 大腸崩壊性硬質カプセル
RU2014105577A (ru) Капсулированная лекарственная форма, содержащая монтелукаст и левоцетиризин
CN101291669A (zh) 氮杂双环已烷衍生物的用途
CN1141589A (zh) 扑热息痛和哌双咪酮的膜包衣片剂
KR20030036877A (ko) 메트포민을 함유하는 지속방출형 약학 조성물 및 이의제조방법
CN114224862A (zh) 一种南极磷虾油凝胶胶囊及其制备方法
CN101669901B (zh) 用于眼部给药的液体制剂及其制备方法
CN1139110A (zh) 抑制3-取代的-2-羟吲哚的光分解
UY25864A1 (es) Derivados de acetamida antagonistas de receptor de nk1
US4242353A (en) Analgesic potentiation
CN1546025A (zh) 泮托拉唑钠肠溶微丸
KR20240120806A (ko) 식물성 심리스 연질캡슐 조성물 및 연질캡슐 제조방법
JPH037220A (ja) アルキルシステインまたはその酸付加塩を含有する安定な錠剤
SK19192000A3 (sk) Použitie paroxetínu alebo jeho farmaceuticky prijateľnej soli alebo solvátu na podporu odvykania od fajčenia alebo na zníženie alebo prevenciu relapsu fajčenia
CA2216931A1 (fr) Inhibition de la photodecomposition des 2-oxindoles-3-substitues
KR100464210B1 (ko) 세푸록심 악세틸 함유 약제학적 조성물 및 그의 제조방법
KR20250159949A (ko) 안정성이 개선된 피타바스타틴을 포함하는 약학 조성물

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee